The metabolic syndrome and its components in postmenopausal women

Gynecological Endocrinology

Volumn 29, Issue 6, 2013, Pages 563-568

  Chedraui, Peter ^a   San Miguel, Glenda ^a   Vintimilla Sigüenza, Isabel ^a   Villacreses, Diego ^a   Romero Huete, Lucía ^a   Domínguez, Andrea ^a   Jaramillo, Winston ^a   Escobar, Gustavo S ^a   Pérez López, Faustino R ^b   Genazzani, Andrea R ^c   Simoncini, Tommaso ^c  

^a UNIVERSIDAD CATÓLICA DE SANTIAGO DE GUAYAQUIL   (Ecuador)

^b UNIVERSITY OF ZARAGOZA   (Spain)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

Insulin resistance; Metabolic syndrome; Obesity; Postmenopause; Risk determinants

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; POSTMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; POSTMENOPAUSE; PREVALENCE; RISK FACTORS;

EID: 84877616606     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2013.788637     Document Type: Article

References (39)

1. Trevisan M, Liu J, Bahsas FB, Menotti A. Syndrome X and mortality: A population-based study. Risk Factor and Life Expectancy Research Group. Am J Epidemiol 1998;148:958-66
2. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-9
3. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). JAMA 2001;285:2486-97
4. Royer M, Castelo-Branco C, Blumel JE, et al. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): Prevalence of the metabolic syndrome in postmenopausal Latin American women. Climacteric 2007;10:164-70
5. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003;88:2404-11
6. Saglam K, Polat Z, Yilmaz MI, et al. Effects of postmenopausal hormone replacement therapy on insulin resistance. Endocrine 2002; 18:211-14
7. Sormova I, Donat J. Risk factors of metabolic estrogen deficiency syndrome in women after menopause and its relationship to hormone replacement therapy. Ceska Gynekol 2004;69:388-96
8. Pérez-Lopez FR, Chedraui P, Gilbert JJ, Pérez-Roncero G. Cardiovascular risk in menopausal women and prevalent related co-morbid conditions: Facing the post-Women's Health Initiative era. Fertil Steril 2009;64:1171-86
9. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the Third National Health and Nutrition Examination Survey. JAMA 2002;287:356-9
10. Hu G, Qiao Q, Tuomilehto J, et al DECODE Study Group. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 2004;164:1066-76
11. Reynolds K, He J. Epidemiology of the metabolic syndrome. Am J Med Sci 2005;330:273-9
12. Wilsgaard T, Jacobsen BK. Lifestyle factors and incident metabolic syndrome The Tromso Study 1979-2001. Diabetes Res Clin Pract 2007;78:217-24
13. Santos AC, Ebrahim S, Barros H. Alcohol intake, smoking, sleeping hours, physical activity and the metabolic syndrome. Prev Med 2007;44:328-34
14. Park YW, Zhu S, Palaniappan L, et al. The metabolic syndrome: Prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003;163:427-36
15. Lakka TA, Laaksonen DE. Physical activity in prevention and treatment of the metabolic syndrome. Appl Physiol Nutr Metab 2007;32:76-88
16. Wada T, Urashima M, Fukumoto T. Risk of metabolic syndrome persists twenty years after the cessation of smoking. Intern Med 2007;46:1079-82
17. Zhang M, Zhao J, Tong W, et al. Associations between metabolic syndrome and its components and alcohol drinking. Exp Clin Endocrinol Diabetes 2011;119:509-12
18. Tonstad S, Sandvik E, Larsen PG, Thelle D. Gender differences in the prevalence and determinants of the metabolic syndrome in screened subjects at risk for coronary heart disease. Metab Syndr Relat Disord 2007;5:174-82
19. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106: 3143-421
20. Grundy SM, Cleeman JI, Daniels SR, et al. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-52
21. Blümel JE, Legorreta D, Chedraui P, et al; for the Collaborative Group for Research of the Climacteric in Latin America (REDLINC). Optimal waist circumference cutoff value for defining the metabolic syndrome in postmenopausal Latin American women. Menopause 2012;19:433-7
22. World Health Organization. Obesity and overweight. Fact sheet N-311. Available from: Http://www.who.int/mediacentre/factsheets/ fs311/en/index.html [last accessed 17 Dec 2012].
23. Castelo-Branco C, Blumel JE, Roncagliolo ME, et al. Age, menopause and hormone replacement therapy influences on cardiovascular risk factors in a cohort of middle-Aged Chilean women. Maturitas 2003;45:205-12
24. Hidalgo LA, Chedraui PA, Morocho N, et al. The metabolic syndrome among postmenopausal women in Ecuador. Gynecol Endocrinol 2006;22:447-54
25. Kim KW, Zhao L, Donato Jr. J, et al. Steroidogenic factor 1 directs programs regulating diet-induced thermogenesis and leptin action in the ventral medial hypothalamic nucleus. Proc Natl Acad Sci USA 2011;108:10673-8
26. Xu Y, Nedungadi TP, Zhu L, et al. Distinct hypothalamic neurons mediate estrogenic effects on energy homeostasis and reproduction. Cell Metab 2011;14:453-65
27. Schwartz MW, Niswender KD. Adiposity signaling and biological defense against weight gain: Absence of protection or central hormone resistance? J Clin Endocrinol Metab 2004;89: 5889-97
28. Cuadros JL, Fernández-Alonso AM, Cuadros AM, et al. Body mass index and its correlation to metabolic and hormone parameters in postmenopausal Spanish women. Gynecol Endocrinol 2011;27: 678-84
29. Kim SK, Kim HJ, Hur KY, et al. Visceral fat thickness measured by ultrasonography can estimate not only visceral obesity but also risks of cardiovascular and metabolic diseases. Am J Clin Nutr 2004;79: 593-9
30. Simó R, Segura RM, García-Pascual L, et al. Fibronectin and diabetes mellitus: The factors that influence its plasma concentrations and its usefulness as a marker of late complications. Med Clin (Barc) 1999;112:45-50
31. Arguin H, Dionne IJ, Sénéchal M, et al. Short-And long-Term effects of continuous versus intermittent restrictive diet approaches on body composition and the metabolic profile in overweight and obese postmenopausal women: A pilot study. Menopause 2012;19:870-6
32. Chedraui P, Jaramillo W, Pérez-López FR, et al. Pro-inflammatory cytokine levels in postmenopausal women with the metabolic syndrome. Gynecol Endocrinol 2011;27:685-91
33. Barriga J, Castelo-Branco C, Chedraui P, et al. Educational and organizational interventions used to improve the knowledge of metabolic syndrome among postmenopausal women. Fertil Steril 2008;90:444-6
34. Lambrinoudaki I, Ceasu I, Depypere H, et al. EMAS position statement: Diet and health in midlife and beyond. Maturitas 2013;74: 99-104
35. De Michele M, Iannuzzi A, Panico S, et al. Effect of high-density lipoprotein cholesterol levels on carotid artery geometry in a Mediterranean female population. Eur J Cardiovasc Prev Rehabil 2004;11:403-7
36. Pérez-López FR, Chedraui P, Haya J, Cuadros JL. Effects of the Mediterranean diet on longevity and age-related morbid conditions. Maturitas 2009;64:67-79
37. Gentile M, Iannuzzi A, Iannuzzo G, et al. Relation of body mass index with carotid intima-media thickness and diameter is independent of metabolic syndrome in postmenopausal Mediterranean women. Menopause 2012;19:1104-8
38. Neuhouser ML, Howard B, Lu J, et al. A low-fat dietary pattern and risk of metabolic syndrome in postmenopausal women: The Women's Health Initiative. Metabolism 2012;61:1572-81
39. Chedraui P, Escobar GS, Ramírez C, et al. Nitric oxide and proinflammatory cytokine serum levels in postmenopausal women with the metabolic syndrome. Gynecol Endocrinol 2012;28:787-91